PlainPharmaWatch

CMS Open Payments · Program Year 2024

Smith+Nephew, Inc.

Smith+Nephew, Inc. reported $50,478,119.45 in payments to 71,450 physicians and teaching hospitals across 72,133 transactions.

See the rankings → How this is sourced
$50.5M
Total payments
72,133
Transactions
71,450
Recipients
+$5.0M
General Payments vs PY2023

Smith+Nephew, Inc. reported $50,478,119.45 in payments to 71,450 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #46 of 1,925 reporting manufacturers (0.4% of all US industry payments), averaging $706.48 per recipient across 13 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Smith+Nephew, Inc. pairs top-5% payment volume with an unusually diversified payment pattern across a wide recipient base.

#46
of 1,925 companies
0.4%
of all US industry payments
0.1%
paid to its single top recipient
13
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Smith+Nephew, Inc.'s CMS-reported General Payments increased by $5.0M (+12.0%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: SMITH+NEPHEW, INC.PY2023: SMITH+NEPHEW, INC.PY2024: Smith+Nephew, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$41.4MPY2024$46.4M
PY2023
$41,400,677.63
PY2024
$46,381,797.94

How Smith+Nephew, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Smith+Nephew, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$50,478,119 Top 2% higher than 98% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Below this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). This entry sits in this band. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Smith+Nephew, Inc.

Averaging $699.79 per transaction and $706.48 per recipient, Smith+Nephew, Inc.'s Program Year 2024 total comes to $50,478,119.45 across 72,133 transactions and 71,450 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #46 of 1,925 companies, representing 0.4% of all industry payments reported nationwide for the year.

The 13-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $24.3M, accounting for 48.1% of the company's reported total and 574 transactions.

General Payment Breakdown by Type

"Royalty or License" leads Smith+Nephew, Inc.'s 13-category general-payment breakdown at $24.3M, 48.1% of the reported total.

How Smith+Nephew, Inc. divides its payments

How the reported total splits across payment categories

1. Royalty or License$24.3M2. Consulting Fee$7.0M3. Grant$4.3M4. Compensation for Services…$3.6M5. Travel and Lodging$2.7M6. Food and Beverage$2.5M7. Acquisitions$827.0K8. Space Rental or Facility …$439.0K9. Debt Forgiveness$406.6K10. Long-Term Medical Supply…$313.4K
Payment Type Amount Transactions
Royalty or License $24.3M 574
Consulting Fee $7.0M 2,069
Grant $4.3M 655
Compensation for Services Other Than Consulting $3.6M 897
Travel and Lodging $2.7M 5,948
Food and Beverage $2.5M 60,636
Acquisitions $827.0K 3
Space Rental or Facility Fees $439.0K 100
Debt Forgiveness $406.6K 75
Long-Term Medical Supply or Device Loan $313.4K 334
Education $19.0K 152
Gift $584.46 3
Entertainment $57.16 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $10,270,131.63 (22.1%) of $46,381,797.94 in this company's General Payments records across 23,896 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Smith+Nephew, Inc.

The five named recipients with the highest reported General Payments from this company

Paul Tornetta III$3.0MWilliam Ricci$2.0MRoy Sanders$1.9MLee Kaplan$1.9MSteven B Haas$1.5M
  1. 1

    Paul Tornetta III

    $3,015,589.80 across 36 reported transactions

  2. 2

    William Ricci

    $2,021,396.94 across 42 reported transactions

  3. 3

    Roy Sanders

    $1,901,786.04 across 28 reported transactions

  4. 4

    Lee Kaplan

    $1,856,442.81 across 4 reported transactions

  5. 5

    Steven B Haas

    $1,474,916.04 across 181 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $699.79. Average per recipient: $706.48.

Total Amount

$50,478,119.45

Avg per Transaction

$699.79

Avg per Recipient

$706.48

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Smith+Nephew, Inc. Share

0.4%

#46 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Smith+Nephew, Inc.

US Retina LLC

$50.8M 8 recipients

Vektor Medical Inc.

$49.6M 56 recipients

Novo Nordisk AS

$49.2M 804 recipients

Sumitomo Pharma America, Inc.

$48.1M 94,811 recipients

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)

$47.9M 137,083 recipients

Cleerly, Inc.

$47.5M 910 recipients

Frequently Asked Questions

How much did Smith+Nephew, Inc. pay to physicians and hospitals in 2024? ▾
0.4% of all industry payments reported to CMS Open Payments for 2024 came from Smith+Nephew, Inc., totaling $50,478,119.45 across 72,133 transactions to physicians and hospitals.
How many physicians received payments from Smith+Nephew, Inc.? ▾
Averaging $706.48 per recipient, Smith+Nephew, Inc.'s 2024 payments reached 71,450 physicians and teaching hospitals.
What types of payments did Smith+Nephew, Inc. make? ▾
13 categories of general payment make up Smith+Nephew, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Royalty or License" at $24.3M, representing 48.1% of the company's reported total.
How does Smith+Nephew, Inc. rank among pharmaceutical companies? ▾
Smith+Nephew, Inc. ranks #46 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Smith+Nephew, Inc.? ▾
The average transaction from Smith+Nephew, Inc. was $699.79 in 2024. The company made 72,133 total transactions to 71,450 recipients.
Where does the payment data for Smith+Nephew, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Smith+Nephew, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.